GlassScriptPhysician profile
Ginger A Trejo
NPI 1336189125
$2,496.53
in general payments reported to CMS, 2019-2025
24 companies · $266 in 2025
The $266 reported for 2025 was more than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $627 · 2022: $638 · 2023: $589 · 2024: $377 · 2025: $266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,231.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $706.70 | 2021-2023 | |
| Revance Therapeutics, INC. | $229.42 | 2024-2025 | Daxxify |
| Galderma Laboratories, L.P. | $212.04 | 2021-2025 | Dysport |
| Mayne Pharma Commercial LLC | $193.50 | 2021-2024 | |
| Myovant Sciences INC. | $140.44 | 2021-2022 | |
| Glaxosmithkline, LLC. | $120.01 | 2023 | Bexsero |
| Biohaven Pharmaceuticals, INC. | $111.94 | 2021 | |
| Astellas Pharma US INC | $93.79 | 2021-2025 | Veozah |
| Sumitomo Pharma America, INC. | $76.66 | 2023 | Myfembree |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $68.54 | 2021 | |
| Exact Sciences Corporation | $68.40 | 2023-2024 | Cologuard Collection Kit |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $67.26 | 2023 | |
| Coloplast Corp | $56.33 | 2023 | Titan |
| Hologic Sales and Service, LLC | $55.39 | 2025 | Aptima, Thinprep 2000 Processor |
| Ascend Therapeutics US, LLC | $55.31 | 2023-2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $52.87 | 2021-2023 | NP Thyroid 60 |
| Pacira Pharmaceuticals Incorporated | $27.96 | 2023 | Exparel |
| Ethicon US, LLC | $26.99 | 2022 | |
| Currax Pharmaceuticals LLC | $26.79 | 2021-2022 | |
| Acella Pharmaceuticals, LLC | $23.70 | 2025 | NP Thyroid 60 |
| Organon LLC | $23.05 | 2022 | |
| Becton, Dickinson and Company | $20.86 | 2024 | Arista Ah Flexitip |
| Lupin INC. | $20.10 | 2021 | |
| Dexcom, INC. | $18.48 | 2025 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ginger Trejo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.